The page lists 20 projects related to the topic "antagonists".
| # | |||
|---|---|---|---|
| 1 | TOLLerant | Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach. | 2015 |
| 2 | HISTHEOL | History and Theology | 2015 |
| 3 | EmotionalActions | Understanding Emotional Actions | 2015 |
| 4 | ER_disease | Defining hormonal cross-talk and the role of mutations in estrogen receptor positive breast cancer | 2015 |
| 5 | SIRENE | Silencing miR-199b to attenuate the progression of heart failure. | 2015 |
| 6 | CaNANObinoids | From Peripheralized to Cell- and Organelle-Targeted Medicine: The 3rd Generation of Cannabinoid-1 Receptor Antagonists for the Treatment of Chronic Kidney Disease | 2016 |
| 7 | eWAD | Unbalanced Wnt signalling in AD: a DNA methylation effect | 2017 |
| 8 | WallWatchers | Plant cell wall communication and remodelling: the wall watchers. | 2017 |
| 9 | EpiPur | The ATP-P2X7R axis: a target for drug-refractory epilepsy | 2018 |
| 10 | PurinesDX | Interdisciplinary training network on the purinergic P2X7 receptor to control neuroinflammation and hyperexcitability in brain diseases. | 2017 |
| 11 | DEFPOLL | Origins of trait diversity in flowering plants: understanding interactions between plant defence and pollination using molecular, phenotypic and ecological studies of natural selection | 2018 |
| 12 | INMIfungi | Interactions of insect and soil microbial communities with insect pathogenic fungi | 2018 |
| 13 | MECHPREDPRO | Cellular mechanisms of predictive processing and its effects on perception | 2018 |
| 14 | EPI-X4Health | Therapeutic potential of optimized derivatives of an endogenous CXCR4 antagonist for the treatment of cancers and inflammatory diseases | 2018 |
| 15 | XEND | Clinical assessment of PILA PHARMA’s TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent | 2019 |
| 16 | BioNeedit | New biological control agents against European fruit tree canker disease (Neonectria ditissima) in apple: from microbiome analysis towards product development | 2019 |
| 17 | TaPPiNG-EPI | Targeting Purinergic Pathway in drug-resistant epilepsy using human Neurons and Glia. | 2019 |
| 18 | Food-PPP-NAFLD | Discovery and characterization of food bioactive compounds modulating the Pentose Phosphate Pathway against non-alcoholic fatty liver disease. | 2019 |
| 19 | NeoPur | New treatments and novel diagnostic tests for neonatal seizures based on purinergic signaling. | 2019 |
| 20 | InflaPML | Promyelocytic leukemia protein (PML) outside the tumor: a new player in the control of inflammation | 2020 |